White Paper Development on Policy Landscape for Bio/Pharma Industry
ADVI conducted significant secondary and primary research with payors and oncologists, as well as Washington policy thought leaders, to identify key trends and potential future approaches to oncology payment reform.
ADVI conducted significant secondary and primary research with payors and oncologists, as well as Washington policy thought leaders, to identify key trends and potential future approaches to oncology payment reform. Also provided detailed analysis and assessment on impact as well as potential advocacy strategies against key threats.
CEO insights
Related articles
Real analysis from people who’ve been there
Evaluation of Biosimilar Utilization by Hospital Types
Worked with a pharmaceutical trade organization to identify biosimilars of interest.
Advocacy Coalition for Uptake of Comprehensive Genomic Profiling
Worked with a diverse group of industry stakeholders including diagnostics manufacturers, laboratories, academic institutions, and disease-specific advocacy groups to redefine comprehensive genomic profiling through the creation of a “new narrative”.
Reach out
Own your edge
We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.